Trials / Completed
CompletedNCT04173767
High-flow Nasal Cannula Oxygen Therapy for Ischemic Stroke Patients With Dysphagia and Obstructive Sleep Apnea
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
High flow nasal cannula (HFNC) ventilation therapy was found to improve the severity of obstructive sleep apnea in non-stroke subjects. The investigators hypothesized that HFNC might be effective in stroke patients with dysphagia who needed nasogastric tube feeding and can not receive continuous positive airway pressure ventilation for obstructive sleep apnea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | high flow nasal cannula ventilation | High-flow nasal cannula (HFNC) ventilation therapy: supply heated \& humidified air up to 60 L/min of flow; effects: positive end expiratory pressure effect, humidification. |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2019-01-31
- Completion
- 2019-01-31
- First posted
- 2019-11-22
- Last updated
- 2019-11-22
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04173767. Inclusion in this directory is not an endorsement.